Telix and Biokosmos Sign Distribution Agreement for Prostate Cancer Imaging in Greece and Cyprus GlobeNewswire January 27, 2022 MELBOURNE, Australia and ATHENS, Greece, Jan. 28, 2022 (GLOBE NEWSWIRE) Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an exclusive commercial distribution agreement with Athens-based BIOKOSMOS.
Investegate announcements from Telix Pharmaceuticals Limited, Telix and Biokosmos Sign Distribution Agreement for Prostate Cancer Imaging in Greece and Cyprus